Mice deficient in PTEN in the prostate developed stable precancers. Androgen deprivation promoted progression to invasive prostate cancer. Patients with PTEN-deficient prostate precancers may not benefit from androgen deprivation chemoprevention therapy. PHILADELPHIA — The use of androgen deprivation...
Posted to
News
by
AACR News
on
Thu, Dec 20 2012
Filed under:
Filed under: Press Releases, Research, Treatment, Cancer, Media Materials, AACR, cancer prevention, American Association for Cancer Research, prevention, genetics, Cancer Discovery, prostate cancer, journal, Dr. Thomas R. Roberts, precancer, androgen deprivation therapy
Higher levels of PFKFB4 found in metastatic prostate tumors. Depletion of this gene inhibited tumor growth in laboratory models. Results suggest a potential new target for therapy. PHILADELPHIA — Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible...
Posted to
News
by
AACR News
on
Thu, Mar 22 2012
Filed under:
Filed under: Press Releases, Research, Cancer, Media Materials, AACR, American Association for Cancer Research, genetics, Cancer Discovery, prostate cancer, journal, Dr. Almut Schulze, cancer cell metabolism, Cancer Research U.K.
Tweet • Differences could explain the higher rates of prostate cancer and mortality.• Understanding differences could lead to specialized treatment. WASHINGTON, D.C. — Genetic differences in prostate cells seem to be a root cause of the prostate cancer...
Posted to
News
by
AACR News
on
Tue, Sep 20 2011
Filed under:
Filed under: Press Releases, Research, Conference, Cancer, Media Materials, AACR, American Association for Cancer Research, genetics, minorities, prostate cancer, Disparities, cancer health disparities, meeting, genes, microRNA, The Science of Cancer Health Disparities, mRNA, Dr. Bi-Dar Wang, men
An executive of the company had his own DNA tested and the results were shocking and unexpected to say the least. Recently deCode Genetics spoke about working more with physicians in the education process of personalized medicine . The test ran by the company he works for showed that he...